Coverage
-
April 05, 2021
The Ninth Circuit on Friday revived allegations from a whistleblower's suit that Medtronic fraudulently obtained U.S. Food and Drug Administration clearance for certain spinal surgery implants, but affirmed the dismissal of other claims alleging the medical device maker offered kickbacks to health care providers and pushed off-label uses of the devices.
1 other articles on this case.
View all »